{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:08:36Z","timestamp":1791464916304,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Subacute Sclerosing Panencephalitis (SSPE) is so rare in developed countries with measles immunization programs that national active surveillance is now needed to capture sufficient number of cases for meaningful analysis of data. Through the Canadian Paediatric Surveillance Program (CPSP), the SSPE study was able to document a national incidence and determine the epidemiology of affected Canadian children.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Between 1997 and 2000, the CPSP surveyed monthly 1978 to 2294 Canadian pediatricians and sub-specialists for SSPE cases. The response rate varied from 82\u201386% over those years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Altogether, four SSPE cases were reported to the CPSP: one case before, two during and one after the study period. The incidence of SSPE in Canadian children was 0.06\/million children\/year. Of the four cases, diagnosed between ages four and 17 years, three children had measles infection in infancy. All children showed a progressive course of dementia, loss of motor skills and epilepsy. Two children were treated with isoprinosine and intraventricular interferon but died in less than three years from disease onset. One child did not have any treatment and died after seven years of illness. One child received intraventricular ribavirin and remains alive, but markedly impaired, nine years following diagnosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The CPSP has demonstrated that Canadian paediatricians and paediatric neurologists may encounter cases of SSPE. This report highlights the clinical course of affected Canadian children and provides a review of the disease and its management.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2431-5-47","type":"journal-article","created":{"date-parts":[[2005,12,16]],"date-time":"2005-12-16T07:15:48Z","timestamp":1134717348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Subacute Sclerosing Panencephalitis: Results of the Canadian Paediatric Surveillance Program and review of the literature"],"prefix":"10.1186","volume":"5","author":[{"given":"Craig","family":"Campbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wikke","family":"Walop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Brannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,12,15]]},"reference":[{"key":"100_CR1","first-page":"585","volume":"31","author":"P Dyken","year":"1982","unstructured":"Dyken P, DuRant R, Shmunes P: Subacute sclerosing panencephalitis surveillance- United States. MMWR. 1982, 31: 585-588.","journal-title":"MMWR"},{"key":"100_CR2","volume-title":"Canadian Pediatric Surveillance Program Protocols","author":"R Pless","year":"1996","unstructured":"Pless R: Subacute sclerosing panencephalitis. Canadian Pediatric Surveillance Program Protocols. 1996"},{"key":"100_CR3","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3109\/13550289909021290","volume":"5","author":"J Schneider-Schaulies","year":"1999","unstructured":"Schneider-Schaulies J, Niewiesk S, Schneider-Schaulies S, ter Meulen V: Measles virus in the CNS: the role of viral and host factors for the establishment and maintenance of a persistent infection. J NeuroVirology. 1999, 5: 613-622.","journal-title":"J NeuroVirology"},{"key":"100_CR4","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1001\/archneur.59.5.822","volume":"59","author":"T Inoue","year":"2002","unstructured":"Inoue T, Kira R, Nakao F, Ihara K, Bassuny WM, Husuhara K, Nihei K, Takeshita K, Hara T: Contribution of the interleukin 4 gene to susceptibility to subacute sclerosing panencephalitis. Arch Neurol. 2002, 59: 822-827. 10.1001\/archneur.59.5.822.","journal-title":"Arch Neurol"},{"key":"100_CR5","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1093\/emboj\/17.14.3899","volume":"17","author":"T Cathomen","year":"1998","unstructured":"Cathomen T, Mrkic B, Spehner D, Drillien R, Naef R, Pavlovic J, Aguzzi A, Billeter MA, Cattaneo R: A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. The EMBO Journal. 1998, 17: 3899-3908. 10.1093\/emboj\/17.14.3899.","journal-title":"The EMBO Journal"},{"key":"100_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0361-9230(97)00139-1","volume":"44","author":"E Norrby","year":"1997","unstructured":"Norrby E, Kristensson K: Measles virus in the brain. Brain Research Bulletin. 1997, 44: 213-220. 10.1016\/S0361-9230(97)00139-1.","journal-title":"Brain Research Bulletin"},{"key":"100_CR7","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1212\/01.WNL.0000106940.95749.8E","volume":"62","author":"H Torisu","year":"2004","unstructured":"Torisu H, Kusuhara K, Kira R, Bassuny WM, Sakai Y, Sanefuji M, Takemoto M, Hara T: Functional M xA promoter polymorphism associated with subacute sclerosing panencephalitis. Neurology. 2004, 62: 457-460.","journal-title":"Neurology"},{"key":"100_CR8","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1177\/08830738020170101101","volume":"17","author":"M Hayashi","year":"2002","unstructured":"Hayashi M, Arai N, Satoh J, Suzuki H, Katayama K, Tamagawa K, Morimatsu Y: Neurodegenerative mechanisms in subacute sclerosing panencephalitis. J Child Neurol. 2002, 17: 725-730.","journal-title":"J Child Neurol"},{"key":"100_CR9","volume-title":"Vaccines","author":"SC Redd","year":"1999","unstructured":"Redd SC, Markowitz LE, Katz SL: Measles vaccine. Vaccines. Edited by: Plotkin SA, Orenstein WA. 1999, Toronto: WB Saunders Company, 233: 3","edition":"3"},{"issue":"suppl 1","key":"100_CR10","doi-asserted-by":"publisher","first-page":"S236","DOI":"10.1086\/378499","volume":"189","author":"A King","year":"2004","unstructured":"King A, Varughese P, DeSerres G, Tipples GA, Waters J: Measles elimination in Canada. JID. 2004, 189 (suppl 1): S236-42. 10.1086\/378499.","journal-title":"JID"},{"key":"100_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1600-0404.1998.tb07377.x","volume":"98","author":"N Zilber","year":"1998","unstructured":"Zilber N, Kahana E: Environment risk factors for subacute sclerosing panencephalitis (SSPE). Acta Neurol Scand. 1998, 98: 49-54.","journal-title":"Acta Neurol Scand"},{"key":"100_CR12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1177\/088307380001500411","volume":"15","author":"P Dimova","year":"2000","unstructured":"Dimova P, Bojinova V: Subacute sclerosing panencephalitis with atypical onset: clinical, computed tomographic, and magnetic resonance imaging correlations. J Child Neurol. 2000, 15: 258-260.","journal-title":"J Child Neurol"},{"issue":"1","key":"100_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0387-7604(96)00071-X","volume":"19","author":"A Tomoda","year":"1997","unstructured":"Tomoda A, Miike T, Miyagawa S, Negi A, Takeshima H: Subacute sclerosing panencephalitis and chorioretinitis. Brain Dev. 1997, 19 (1): 55-57. 10.1016\/S0387-7604(96)00071-X.","journal-title":"Brain Dev"},{"key":"100_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0887-8994(95)00145-6","volume":"13","author":"ML Nunes","year":"1995","unstructured":"Nunes ML, Costa Da Costa J, Garcias Da Silva LF: Trihexyphenidyl and isoprinosine in the treatment of subacute sclerosing panencephalitis. Pediat Neurol. 1995, 13: 153-156. 10.1016\/0887-8994(95)00145-6.","journal-title":"Pediat Neurol"},{"key":"100_CR15","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/0387-7604(93)90120-W","volume":"15","author":"G Gascon","year":"1993","unstructured":"Gascon G, Yamani S, Crowell J, Stigsby B, Nester M, Kanaan I, Jallu A: Combined oral isoprinosine-intra-ventricular \u03b1-interferon therapy for subacute sclerosing panencephalitis. Brain Dev. 1993, 15: 346-355. 10.1016\/0387-7604(93)90120-W.","journal-title":"Brain Dev"},{"issue":"3","key":"100_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/000992289703600306","volume":"36","author":"R PeBenito","year":"1997","unstructured":"PeBenito R, Naqvi SH, Arca MM, Schubert R: Fulminating subacute sclerosing panencephalitis: case report and literature review. Clin Pediatr. 1997, 36 (3): 149-154.","journal-title":"Clin Pediatr"},{"key":"100_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0887-8994(98)00100-3","volume":"20","author":"Y Sawaishi","year":"1999","unstructured":"Sawaishi Y, Abe T, Yano T, Ishikawa K, Takada G: SSPE following neonatal measles infection. Pediat Neurol. 1999, 20: 63-65. 10.1016\/S0887-8994(98)00100-3.","journal-title":"Pediat Neurol"},{"key":"100_CR18","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1212\/WNL.47.5.1278","volume":"47","author":"B Anlar","year":"1996","unstructured":"Anlar B, Saatci I, Kose G, Yalaz K: MRI findings in subacute sclerosing panencephalitis. Neurology. 1996, 47: 1278-1283.","journal-title":"Neurology"},{"key":"100_CR19","first-page":"892","volume":"25","author":"RN Sener","year":"2004","unstructured":"Sener RN: Subacute sclerosing panencephalitis findings at MR imaging, diffusion MR imaging and proton MR spectroscopy. AJNR. 2004, 25: 892-894.","journal-title":"AJNR"},{"key":"100_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/088307380201700106","volume":"17","author":"A Ozturk","year":"2002","unstructured":"Ozturk A, Gurses C, Baykan B, Gokyig*it A, Eraksoy M: Subacute sclerosing panencephalitis: clinical and magnetic resonance imaging evaluation of 36 patients. J Child Neurol. 2002, 17: 25-29.","journal-title":"J Child Neurol"},{"key":"100_CR21","first-page":"501","volume":"24","author":"A Alkan","year":"2003","unstructured":"Alkan A, Sarac K, Kutlu R, Yakinci C, Sigirci A, Aslan M, Baysal T: Early and late-state subacute sclerosing panencephalitis: chemical shift imaging and single voxel MR spectroscopy. AJNR. 2003, 24: 501-506.","journal-title":"AJNR"},{"key":"100_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1177\/088307389601100301","volume":"11","author":"MJ Nester","year":"1996","unstructured":"Nester MJ: Use of a brief assessment examination in a study of subacute sclerosing panencephalitis. J Child Neurol. 1996, 11: 173-180.","journal-title":"J Child Neurol"},{"key":"100_CR23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/ana.410110407","volume":"11","author":"PR Dyken","year":"1982","unstructured":"Dyken PR, Swift A, DuRant RH: Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex. Ann Neurol. 1982, 11: 359-364. 10.1002\/ana.410110407.","journal-title":"Ann Neurol"},{"key":"100_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2165\/00003495-198122020-00002","volume":"22","author":"TW Chang","year":"1981","unstructured":"Chang TW, Heel RC: Ribavirin and inosiplex: a review of their present status in viral diseases. Drugs. 1981, 22: 111-128.","journal-title":"Drugs"},{"key":"100_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2165\/00023210-199707020-00003","volume":"7","author":"B Anlar","year":"1997","unstructured":"Anlar B: Subacute sclerosing panencephalitis: Diagnosis and drug treatment options. CNS Drugs. 1997, 7: 111-120.","journal-title":"CNS Drugs"},{"key":"100_CR26","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1177\/088307389801301106","volume":"13","author":"B Anlar","year":"1998","unstructured":"Anlar B, Yalaz K, Kose G, Saygi S: \u03b2-Interferon plus inosiplex in the treatment of subacute sclerosing panencephalitis. J Child Neurol. 1998, 13: 557-559.","journal-title":"J Child Neurol"},{"key":"100_CR27","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1177\/088307380301801201","volume":"18","author":"G Gascon","year":"2003","unstructured":"Gascon G: Randomized treatment of inosiplex versus combined inosiplex and intra-ventricular interferon-alpha in subacute sclerosing panencephalitis (SSPE): international multicentre study. J Child Neurol. 2003, 18: 819-832.","journal-title":"J Child Neurol"},{"key":"100_CR28","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1212\/WNL.48.2.526","volume":"48","author":"B Anlar","year":"1997","unstructured":"Anlar B, Yalaz K, Oktem F, Kose G: Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular \u03b1-interferon. Neurology. 1997, 48: 526-528.","journal-title":"Neurology"},{"issue":"3","key":"100_CR29","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/BF02337487","volume":"8","author":"A Boiardi","year":"1987","unstructured":"Boiardi A, Baldini SM, Sghirlanzoni A, Mancuso R, Corridori F: Intraventricular interferon in a case of subacute sclerosing panencephalitis. Ital J Neurol Sci. 1987, 8 (3): 277-281.","journal-title":"Ital J Neurol Sci"},{"issue":"8","key":"100_CR30","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1177\/088307389701200803","volume":"12","author":"NM Fayad","year":"1997","unstructured":"Fayad NM, Yamout BI, Mroueh S: Alpha-interferon in the treatment of subacute sclerosing panencephalitis. J Child Neurol. 1997, 12 (8): 486-488.","journal-title":"J Child Neurol"},{"issue":"4","key":"100_CR31","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1212\/WNL.36.4.562","volume":"36","author":"HS Panitch","year":"1986","unstructured":"Panitch HS, Gomez-Plascencia J, Norris FH, Cantell K, Smith RA: Subacute sclerosing panencephalitis: remission after treatment with intravenous interferon. Neurology. 1986, 36 (4): 562-566.","journal-title":"Neurology"},{"issue":"3","key":"100_CR32","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1600-0404.1988.tb03639.x","volume":"78","author":"D Maimone","year":"1988","unstructured":"Maimone D, Grimaldi LM, Incorpora G, Biondi R, Sofia V, Mancuso GR, Siciliano L, Ruscica M, Pavone L: Intrathecal interferon in subacute sclerosing panencephalitis. Acta Neurol Scand. 1988, 78 (3): 161-166.","journal-title":"Acta Neurol Scand"},{"key":"100_CR33","first-page":"20","volume":"43","author":"KPS Nair","year":"1995","unstructured":"Nair KPS, Swamy HS, Arunodaya GR, Ravi V, Taly AB: Intravenous with intrathecal interferon in subacute sclerosing panencephalitis. Neurol India. 1995, 43: 20-25.","journal-title":"Neurol India"},{"key":"100_CR34","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S0387-7604(87)80044-X","volume":"9","author":"Y Fukuyama","year":"1987","unstructured":"Fukuyama Y, Nihei K, Matsumoto S, Ebina T, Kamoshita S, Sato T, Arima M, Yabuuchi H, Ueda S, Ohtahara S, Takeshita K, Kurokawa T, Ishida N, Okuno Y, Tateishi J, Sakuma A: Clinical effects of MND-19 (Inosiplex) on subacute sclerosing panencephalitis. Brain Dev. 1987, 9: 270-282.","journal-title":"Brain Dev"},{"issue":"3 Pt 1","key":"100_CR35","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1212\/WNL.42.3.488","volume":"42","author":"K Yalaz","year":"1992","unstructured":"Yalaz K, Anlar B, Oktem F, Aysun S, Ustacelebi S, Gurcay O, Gucuyener K, Renda Y: Intraventricluar interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis. Neurology. 1992, 42 (3 Pt 1): 488-491.","journal-title":"Neurology"},{"key":"100_CR36","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/S0140-6736(82)92097-9","volume":"1","author":"C Jones","year":"1982","unstructured":"Jones C, Dyken P, Huttenlocher P, Jabbour JT, Maxwell K: Inosiplex therapy in subacute sclerosing panencephalitis. Lancet. 1982, 1: 1034-1037. 10.1016\/S0140-6736(82)92097-9.","journal-title":"Lancet"},{"issue":"7","key":"100_CR37","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/00006454-199307000-00006","volume":"12","author":"B Anlar","year":"1993","unstructured":"Anlar B, Gucuyener K, Imir T, Yalaz K, Renda Y: Cimetidine as an immunomodulator in subacute sclerosing panencephalitis: a double blind, placebo-controlled study. Pediatr Infect Dis J. 1993, 12 (7): 578-581.","journal-title":"Pediatr Infect Dis J"},{"key":"100_CR38","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0887-8994(00)00233-2","volume":"24","author":"A Tomoda","year":"2001","unstructured":"Tomoda A, Shiraishi S, Hosoya M, Hamada A, Miike T: Combined treatment with interferon-alpha and ribavirin for subacute sclerosing panencephalitis. Pediat Neurol. 2001, 24: 54-59. 10.1016\/S0887-8994(00)00233-2.","journal-title":"Pediat Neurol"},{"key":"100_CR39","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/0887-8994(95)00257-X","volume":"14","author":"Y Gurer","year":"1996","unstructured":"Gurer Y, Kukners S, Sarica B: Intravenous \u03b3-globulin treatment in a patient with subacute sclerosing panencephalitis. Pediat Neurol. 1996, 14: 72-74. 10.1016\/0887-8994(95)00257-X.","journal-title":"Pediat Neurol"},{"key":"100_CR40","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1071-9091(99)80008-4","volume":"6","author":"GB Bobele","year":"1999","unstructured":"Bobele GB: Subacute encephalopathy in a 5-year-old boy. Sem Pediat Neurol. 1999, 6: 68-172.","journal-title":"Sem Pediat Neurol"},{"key":"100_CR41","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1212\/01.WNL.0000142090.62214.61","volume":"63","author":"S Honarmand","year":"2004","unstructured":"Honarmand S, Glaser CA, Chow E, Sejvar JJ, Preas CP, Cosentino GC, Hutchison HT, Bellini WJ: Subacute sclerosing panencephalitis in the differential diagnosis of encephalitis. Neurology. 2004, 63: 1489-1493.","journal-title":"Neurology"},{"key":"100_CR42","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000079952","volume":"23","author":"V Bojinova","year":"2004","unstructured":"Bojinova V, Domova P, Belopitova L, Mihailov A, Gatcheva N, Mihneva Z, Todorova M: Subacute sclerosing panencephalitis in Bulgaria (1978\u20132002). Neuroepidemiology. 2004, 23: 254-257. 10.1159\/000079952.","journal-title":"Neuroepidemiology"},{"key":"100_CR43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejpn.2003.11.007","volume":"8","author":"V Bojinova","year":"2004","unstructured":"Bojinova V, Domova P, Belopitova L, Mihailov A, Gatcheva N, Mihneva Z, Hristova MT: Clinical and epidemiologic characteristics of subacute sclerosing panencephalitis in Bulgaria during the past 25 years (1978\u20132002). Eur J Pediatr Neurol. 2004, 8: 89-94. 10.1016\/j.ejpn.2003.11.007.","journal-title":"Eur J Pediatr Neurol"},{"key":"100_CR44","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.pediatrneurol.2003.11.010","volume":"31","author":"P Ip","year":"2004","unstructured":"Ip P, Chung BHY, Wong VCN, Chan K: Subacute sclerosing panencephalitis in children: Prevalence in South China. Pediatr Neurol. 2004, 31: 46-51. 10.1016\/j.pediatrneurol.2003.11.010.","journal-title":"Pediatr Neurol"},{"key":"100_CR45","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1136\/adc.2003.038489","volume":"89","author":"C Miller","year":"2004","unstructured":"Miller C, Andrew N, Rush M, Munro H, Jin L, Miller E: The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990\u20132002. Arch Dis Child. 2004, 89: 1145-1148. 10.1136\/adc.2003.038489.","journal-title":"Arch Dis Child"},{"key":"100_CR46","first-page":"21","volume":"36","author":"K Hirayasu","year":"2004","unstructured":"Hirayasu K, Nakada Y, Oshirs S, Takaesu E, Nakamura K, Shiroma N, Minema H: Epidemiology of subacute sclerosing panencephalitis in Okinawa Japan \u2013 the second report 1977\u20131999. Brain Dev. 2004, 36: 21-25.","journal-title":"Brain Dev"},{"key":"100_CR47","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1017\/S0950268803008999","volume":"131","author":"T Takasu","year":"2003","unstructured":"Takasu T, Mgone JM, Mgone CS, Miki K, Komase K, Namae H, Saito Y, Kokubun Y, Nishimura T, Kawanishi R, Mizutani T, Markus TJ, Kono J, Asuo PG, Alpers MP: A continuing high incidence of subactuce sclerosing panaencephalitis (SSPE) in the Eastern Highlands of Papua New Guinea. Epidemiol Infect. 2003, 131: 887-898. 10.1017\/S0950268803008999.","journal-title":"Epidemiol Infect"},{"key":"100_CR48","first-page":"17","volume-title":"Australian Paediatric Surveillance Unit Sixth Annual Report","author":"J Hanna","year":"1998","unstructured":"Hanna J, Messer R, Procopis P: Subacute sclerosing panencephalitis. Australian Paediatric Surveillance Unit Sixth Annual Report. 1998, 17-18."},{"key":"100_CR49","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1590\/S0004-282X1999000200002","volume":"57","author":"ML Nunes","year":"1999","unstructured":"Nunes ML, Costa Da Costa H, Stancher VM, Diament A, Arita F, Rosemberg S, Dyken P: Subacute sclerosing panencephalitis. Arq Neuropisiquiatr. 1999, 57: 176-181.","journal-title":"Arq Neuropisiquiatr"},{"issue":"5","key":"100_CR50","first-page":"626","volume":"25","author":"W Sobczyk","year":"1991","unstructured":"Sobczyk W, Kulczycki J, Pilkowska B, Milewska D, Szmigielski S: Comparison of the results of the treatment of patients with SSPE using various immunomodulating preparations. Neurol Neurochir Pol. 1991, 25 (5): 626-633.","journal-title":"Neurol Neurochir Pol"},{"key":"100_CR51","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/08830738030180020701","volume":"18","author":"FO Aydin","year":"2003","unstructured":"Aydin FO, Senbil N, Kuyucu N, Gurer Y: Combined treatment with subcutaneous interferon-\u03b1, oral isoprinosine, and lamivudine for subacute sclerosing panencephalitis. J Child Neurol. 2003, 18: 104-108.","journal-title":"J Child Neurol"},{"key":"100_CR52","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0387-7604(03)00062-7","volume":"25","author":"A Tomoda","year":"2003","unstructured":"Tomoda A, Nomura K, Shiraishi S, Hamada A, Ohmura T, Hosoya M, Miike T, Sawaishi Y, Kimura H, Takashima H, Tohda Y, Mori K, Kato Z, Fukushima A, Nishio H, Nezu A, Nihei K: Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis. Brain Dev. 2003, 25: 514-517. 10.1016\/S0387-7604(03)00062-7.","journal-title":"Brain Dev"},{"key":"100_CR53","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1212\/WNL.50.1.315","volume":"50","author":"C Cianchetti","year":"1998","unstructured":"Cianchetti C, Marrosu MG, Muntoni F, Fratta A, Zuddas A: Intraventricular \u03b1-interferon in subacute sclerosing panencephalitis. Neurology. 1998, 50: 315-316. 10.1159\/000023297.","journal-title":"Neurology"},{"key":"100_CR54","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0387-7604(89)80012-9","volume":"11","author":"S Kuroki","year":"1989","unstructured":"Kuroki S, Tsutsui T, Yoshioka M, Mizue H, Kita M, Kishida T: The effect of intraventricular interferon on subacute sclerosing panencephalitis. Brain Dev. 1989, 11: 65-69.","journal-title":"Brain Dev"},{"key":"100_CR55","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1001\/archneur.1979.00500420084012","volume":"36","author":"R Silverberg","year":"1979","unstructured":"Silverberg R, Brenner T, Abramsky O: Inosiplex in the treatment of subacute sclerosing panencephalitis. Arch Neurol. 1979, 36: 374-375.","journal-title":"Arch Neurol"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-5-47.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2431-5-47\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-5-47","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2431-5-47.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T22:31:49Z","timestamp":1630708309000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/1471-2431-5-47"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["100"],"URL":"https:\/\/doi.org\/10.1186\/1471-2431-5-47","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"19 April 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"47"}}